Of urban heart health and AI
Novartis Foundation
We help cities tackle cardiovascular disease and advance health equity through data and AI.
Did you know? Only 20% of your health outcomes are determined by the healthcare you receive. Conversely, the conditions in which you are born, grow and work shape up to 80% [1]. And with the arrival of new technologies, we can analyze and understand what truly drives our health.
The emergence of Artificial Intelligence (AI) systems in our daily lives has taken the world by storm - from providing instant human-like answers to our questions to protecting us from cyber threats and issuing warnings about potentially hazardous weather. However, AI can go beyond responding to prompts about cooking recipes and city-trip itineraries. Within healthcare, AI has the potential to bring significant benefits by overcoming barriers that may hinder people from receiving the care they need. Applying AI to analyze large and disconnected sets of health and health-influencing data can support a much-needed paradigm shift from reactive care systems into proactive, predictive, and preventive health systems that keep people healthy.
What determines our risk of developing a disease?
There is a broad public consensus about specific behaviors and habits that can be detrimental to our health. Take cardiovascular disease (CVD), the world's leading cause of death and disability [2] - one of the most important advances in CVD research within the last century has been the identification of risk factors such as smoking, unhealthy diets, and lack of physical activity to name only a few.
That said, there are many more factors that might tip the scales of your health: so called social determinants of health (SDoH) encompass economic (e.g., employment, financial situation), social (e.g., immigration status, acculturation), environmental (e.g., climate, air pollution, transportation), digital (e.g., access to internet or a computing device) and psychosocial factors (e.g., local language, literacy) that may influence our risk of developing a disease, our ability to receive healthcare, and our expected health outcomes [3]. These determinants, however, are not well-understood yet.
?
“Deciphering the true drivers of CVD and how they interact offers the potential to identify people at higher risk of cardiovascular events and thus transform the health of large populations,” explains Dr. Ann Aerts, Head of the Novartis Foundation.
Such an increased understanding of the true determinants of cardiovascular events, like heart attacks or strokes, allows people, health professionals and health system managers alike to make informed decisions on where to allocate resources and capacities to improve population health.
AI4HealthyCities
AI4HealthyCities is an initiative by the Novartis Foundation in collaboration with 微软 AI for Health and local partners, which brings together existent but disconnected sets of data within a city and using advanced analytics and AI to uncover cardiovascular risk factors its population.
With an aim to provide decision makers with insights into the origins of disparities in cardiovascular health outcomes in their jurisdiction, AI4HealthyCities gathers data from health- and health-related sectors and identifies relevant and informative patterns within the data. Elizabeth Adamson , Associate Director of Population Health at the Novartis Foundation, states “We aim to enable informed decision making and design effective interventions by local stakeholders and governments to address critical health problems like CVD.”
However, the need for complex data sets that allow for thorough analysis poses a particular challenge in lower income settings, where some of the highest burden of the disease exists. Therefore, the focus for AI4HealthyCities currently is on data-rich environments, with learnings and insights potentially to be applied to less data-rich environments. As William Brinson Weeks, MD, PhD, MBA , Director at Microsoft AI for Health, states, “With enough longitudinal data, we could use AI to model anticipated effects of a change in social determinants of health on a cardiovascular outcome for a particular population.”
The AI advanced analytics steps that are implemented within AI4HealthyCities include:
领英推荐
Analyses in action
New York, where inhabitants of high-poverty neighborhoods are 2.4 times more likely to die prematurely from CVD than people living in wealthier parts of town [4], was the first city to launch AI4HealthyCities in September 2022.
Since its launch, New York has brought together the data from multiple public sources and from different electronic health records (EHR) to understand the factors driving disparities in cardiovascular health outcomes at an individual zip code or census tract level within New York and across the US. Examples of these different data include (but are not limited to)
Collating these vast amounts of data for New York requires extensive time and effort and has been the focus of NYU School of Global Public Health and Weill Cornell Medicine over the last year. Yongkang Zhang , Assistant Professor of Population Health Sciences at Weill Cornell working on this initiative, mentions that “the unique aspect of this program, compared to many other previous ones, is that we will be using very comprehensive data to enable more accurate predictions.”
Insights may soon shed light on the factors contributing to poor cardiovascular outcomes among individuals residing in one zip code/census tract in New York as compared to those living in a neighboring zip code or tract just a short stroll away.
From data analysis to translation into action
The next step in New York will be to use the newly generated data insights to create a roadmap for improving cardiovascular health outcomes in the city population, and to provide city authorities at the Department of Health and Mental Hygiene with the tools and insights that allow them to target resources for CV health so that they can have the largest impact on the health of the greatest number of people. The data-driven insights may also require involvement of other governing bodies, which could go as far as the departments for urban planning, transport, or education. To support such fundamental data-driven decision making, the AI in the AI4HealthyCities initiative hopes to enable simulations of cost and effectiveness of different population health interventions, so that decision makers can assess the benefit of different types of interventions on cardiovascular outcomes in the city population.
AI cannot replace human knowledge however, and neither can it properly understand a community’s health context; local and cultural knowledge of community perspectives and priorities are also needed. That’s why the city of New York has announced the creation of an expert council to guide the implementation and translation of AI4HealthyCities findings into action. It will provide expert guidance on the preliminary results from the advanced analytics within the local AI4HealthyCities program and ensure independent feedback on how to proceed with cardiovascular health interventions at the population level.
Through the power of data and strong multi-sector partnerships, AI4HealthyCities has the potential to narrow health inequities worldwide. Since 2022, the initiative has launched in other major cities including Singapore, Lausanne and Basel, Switzerland, and soon Helsinki, Finland.
Learn more about the Novartis Foundation and AI4HealthyCities at www.novartisfoundation.org/AI4HealthyCities.?
[1] Hood, C. M., Gennuso, K. P., Swain, G., & Catlin, B. B. (2016). County health rankings. American Journal of Preventive Medicine, 50(2), 129–135. https://doi.org/10.1016/j.amepre.2015.08.024 ???
[2] World Health Organization (2023). Cardiovascular diseases. Retrieved August 17, 2023, from https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1
[3] Powell-Wiley, T. M., Baumer, Y., Baah, F. O., Baez, A. S., Farmer, N., Mahlobo, C. T., Pita, M. A., Potharaju, K. A., Tamura, K., & Wallen, G. R. (2022). Social determinants of cardiovascular disease. Circulation Research, 130(5), 782–799. https://doi.org/10.1161/circresaha.121.319811
[4] Gresia V, Wright M, Li W, Jasek J, Sun Y, Di Lonardo S, Chamany S. Premature Heart Disease and Stroke Deaths in New York City. New York City Department of Health and Mental Hygiene: Epi Data Brief (95); November 2017.
President, Biomedical Research at Novartis
1 年There’s so much potential for AI to help us improve outcomes for patients – from augmenting our ability to find new drug targets and biomarkers, to providing the insights we need to ensure that our medicines and clinical trials are designed with patient needs in mind. AI4HealthyCities is a great example of the type of collaborations we need to make sure everyone stands to benefit from this transformational technology.
Championing tech innovation, education & value-based care for healthier communities.
1 年Tora Newcomer
President, Global Health and Swiss Country Affairs at Novartis
1 年Very insightful, Ann and team! The AI4HealthyCities initiative is a great example of how strong partnerships of like-minded organizations can help us to increase our understanding of local environmental and socio-economic determinants of health, as well as design effective policies that keep people healthy. Thanks to the entire Novartis Foundation team for driving this movement.
Congratulations Ann! This is really great work and will start to change the way CVD is managed
We'd like to extend our sincere thanks to our global and local partners: Microsoft AI for Health, Microsoft AI for Good, NYU School of Global Public Health, Weill Cornell Medicine, NYC Health + Hospitals, NYC Department of Health and Mental Hygiene and many, many more.